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Background
Juvenile Idiopathic Arthritis (JIA) is a complex autoim-
mune disorder likely to be determined by multiple
genetic and environmental factors. Mounting evidence
shows that epigenetic variation influences autoimmune
disease risk. The most well-studied epigenetic mark is
DNA methylation; increased methylation of CpG dinu-
cleotides can reduce gene expression. Nothing is cur-
rently known about the role of methylation in JIA. In
2008, we established CLARITY, a JIA Biobank that is
collecting biospecimens and extensive information about
environment from cases presenting to the Royal Chil-
dren’s Hospital (RCH), Melbourne, Australia. A control
sample of healthy children attending the RCH Day
Surgery Unit has also been collected.
Aims
To identify key differences in methylation patterns
across the genome associated with the most common
subtypes of JIA.
Methods
DNA was isolated from peripheral blood mononuclear
cell CD3+ CD4+ T cells obtained from incident oligoar-
ticular (n = 10) and polyarticular (n = 4) JIA cases, and
healthy age and sex matched controls (N = 14). Bisulfite
converted DNA was applied to genome-wide methyla-
tion arrays (Illumina Infinium HumanMethylation27
Beadchips).
Results
Methylation at ~27,000 CpGs across the genome was
measured in cases and controls. Data was of high quality,
with tight replication between technical replicates. Methy-
lation was significantly different at 86 CpG sites between
our cases and controls, following adjustment for false dis-
covery rate (FDR). Ontology analyses revealed a significant
bias towards immune system-related genes. Of particular
interest was LONRF2, which has been associated with
multiple autoimmune diseases, including rheumatoid
arthritis. This gene showed a consistently increased degree
of methylation in oligoarticular JIA cases when compared
to controls. Consistent with these findings, work by others
has demonstrated decreased LONRF2 expression in JIA.
Conclusions
Our data suggests methylation is relevant to JIA disease
risk. Further work will include in depth investigation of
candidate genes such as LONRF2, concurrent gene
expression analyses, and application of further samples
to new-generation Infinium methylation arrays that
measure over 450,000 CpG sites across the genome.
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